tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market
Advertisement

Protagonist Therapeutics (PTGX) Ratios

Compare
689 Followers

Protagonist Therapeutics Ratios

PTGX's free cash flow for Q2 2025 was $0.00. For the 2025 fiscal year, PTGX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
16.97 16.71 7.61 7.74 7.84
Quick Ratio
16.97 16.71 7.62 7.55 7.74
Cash Ratio
4.75 8.78 4.03 2.81 2.92
Solvency Ratio
1.07 -3.56 -0.16 -2.51 -1.46
Operating Cash Flow Ratio
1.11 -3.30 -3.47 -2.45 -1.80
Short-Term Operating Cash Flow Coverage
18.20 0.00 -43.00 -49.03 -49.68
Net Current Asset Value
$ 552.54M$ 334.30M$ -547.33M$ 293.06M$ 270.74M
Leverage Ratios
Debt-to-Assets Ratio
0.02 <0.01 0.01 0.02 0.02
Debt-to-Equity Ratio
0.02 <0.01 >-0.01 -0.01 -0.02
Debt-to-Capital Ratio
0.02 <0.01 >-0.01 -0.01 -0.02
Long-Term Debt-to-Capital Ratio
0.01 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.07 1.06 -0.46 -0.85 -1.14
Debt Service Coverage Ratio
10.89 0.00 -50.65 -54.61 -31.58
Interest Coverage Ratio
0.00 0.00 0.00 0.00 -107.89
Debt to Market Cap
<0.01 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
0.18 0.02 0.07 0.13 0.19
Net Debt to EBITDA
-6.19 2.05 0.93 0.96 1.75
Profitability Margins
Gross Profit Margin
99.70%100.00%96.12%89.86%100.00%
EBIT Margin
11.77%-156.09%-494.24%-460.01%-224.42%
EBITDA Margin
12.47%-150.57%-494.24%-449.87%-222.38%
Operating Profit Margin
11.77%-156.09%-494.24%-460.01%-225.36%
Pretax Profit Margin
26.41%-131.59%-479.26%-458.94%-226.51%
Net Profit Margin
25.55%-131.59%-464.29%-448.25%-231.07%
Continuous Operations Profit Margin
25.55%-131.59%-479.26%-458.94%-231.07%
Net Income Per EBT
96.76%100.00%96.88%97.67%102.01%
EBT Per EBIT
224.31%84.31%96.97%99.77%100.51%
Return on Assets (ROA)
7.25%-22.06%-49.78%-35.27%-20.39%
Return on Equity (ROE)
8.12%-23.45%22.99%29.96%23.31%
Return on Capital Employed (ROCE)
3.51%-27.82%-60.61%-41.44%-22.70%
Return on Invested Capital (ROIC)
3.39%-27.72%-57.39%-39.90%-22.92%
Return on Tangible Assets
7.25%-22.06%-49.78%-35.27%-20.32%
Earnings Yield
1.44%-6.07%-23.07%-7.74%-9.54%
Efficiency Ratios
Receivables Turnover
0.00 5.81 511.17 17.47 11.80
Payables Turnover
0.00 0.00 0.28 1.73 0.00
Inventory Turnover
0.00 0.00 -10.98 0.33 0.00
Fixed Asset Turnover
16.04 27.92 5.75 4.06 4.46
Asset Turnover
0.28 0.17 0.11 0.08 0.09
Working Capital Turnover Ratio
0.36 0.22 0.11 0.10 0.15
Cash Conversion Cycle
0.00 62.85 -1.32K 928.86 30.93
Days of Sales Outstanding
0.00 62.85 0.71 20.89 30.93
Days of Inventory Outstanding
0.00 0.00 -33.25 1.12K 0.00
Days of Payables Outstanding
0.00 0.00 1.29K 210.45 0.00
Operating Cycle
0.00 62.85 -32.53 1.14K 30.93
Cash Flow Ratios
Operating Cash Flow Per Share
0.62 -1.24 -2.20 -2.33 -2.11
Free Cash Flow Per Share
0.58 -1.25 -2.22 -2.35 -2.12
CapEx Per Share
0.04 0.01 0.02 0.02 0.01
Free Cash Flow to Operating Cash Flow
0.94 1.01 1.01 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
16.19 -115.33 -136.02 -97.97 -153.89
Capital Expenditure Coverage Ratio
16.19 -115.33 -136.02 -97.97 -153.89
Operating Cash Flow Coverage Ratio
3.51 -61.56 -29.58 -18.41 -12.16
Operating Cash Flow to Sales Ratio
0.19 -1.17 -4.07 -3.94 -2.53
Free Cash Flow Yield
1.05%-5.44%-20.36%-6.88%-10.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
69.23 -16.49 -4.34 -12.92 -10.48
Price-to-Sales (P/S) Ratio
17.33 21.69 20.13 57.91 24.22
Price-to-Book (P/B) Ratio
5.39 3.87 -1.00 -3.87 -2.44
Price-to-Free Cash Flow (P/FCF) Ratio
95.11 -18.37 -4.91 -14.54 -9.50
Price-to-Operating Cash Flow Ratio
91.10 -18.53 -4.95 -14.69 -9.57
Price-to-Earnings Growth (PEG) Ratio
-12.18 0.37 0.88 -0.34 0.29
Price-to-Fair Value
5.39 3.87 -1.00 -3.87 -2.44
Enterprise Value Multiple
132.74 -12.35 -3.14 -11.92 -9.14
Enterprise Value
3.37B 1.12B 412.96M 1.47B 582.03M
EV to EBITDA
132.74 -12.35 -3.14 -11.92 -9.14
EV to Sales
16.56 18.60 15.54 53.60 20.33
EV to Free Cash Flow
90.87 -15.75 -3.79 -13.46 -7.98
EV to Operating Cash Flow
85.26 -15.89 -3.82 -13.60 -8.03
Tangible Book Value Per Share
10.52 5.93 -10.94 6.48 8.13
Shareholders’ Equity Per Share
10.52 5.93 -10.94 -8.84 -8.25
Tax and Other Ratios
Effective Tax Rate
0.03 0.00 0.03 0.02 -0.02
Revenue Per Share
3.21 1.06 0.54 0.59 0.83
Net Income Per Share
0.82 -1.39 -2.52 -2.65 -1.92
Tax Burden
0.97 1.00 0.97 0.98 1.02
Interest Burden
2.24 0.84 0.97 1.00 1.01
Research & Development to Revenue
0.71 2.00 4.75 4.61 2.60
SG&A to Revenue
0.20 0.56 1.19 0.99 0.65
Stock-Based Compensation to Revenue
0.22 0.49 0.91 0.60 0.28
Income Quality
0.76 0.89 0.85 0.86 1.10
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis